You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ctDNA

Showing 26 - 50 of 1,216
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 18, 2023

Colorectal Cancer, Liver Metastases, Circulating Tumor Cell Trial in GuangZhou (Colorectal cancer resection combined with liver

Recruiting
  • Colorectal Cancer
  • +3 more
  • Colorectal cancer resection combined with liver metastasis resection.
  • FOLFOX chemotherapy regimen
  • GuangZhou, Guangdong, China
    The Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 14, 2023

Pre-analytical Factors Affecting ctDNA Analysis in Early and

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +4 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jul 6, 2023

Glioblastoma Trial in Zhengzhou (Individualized intervention based on genomic alterations)

Enrolling by invitation
  • Glioblastoma
  • Individualized intervention based on genomic alterations
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Sep 10, 2022

Pancreatic Cancer, Locally Advanced Trial in Beijing (Later-line therapy)

Recruiting
  • Pancreatic Cancer
  • Locally Advanced
  • Later-line therapy
  • Beijing, China
    Department of Medical Oncology, Peking Union Medical College Hos
Apr 10, 2023

Circulating Tumor DNA (ctDNA) in Late-stage Breast Cancer

Completed
  • Metastatic Breast Cancer
  • +2 more
  • ctDNA testing
  • (no location specified)
Jun 16, 2022

ctDNA-based Minimal Residual Disease Detection for Resected

Not yet recruiting
  • Pancreatic Cancer Resectable
  • ctDNA-based MRD detection
  • Shanghai, Shanghai, China
    Ruijin Hospital Affiliated to Shanghai Jiao Tong University Scho
Jul 29, 2022

Disease Burden, Genetic Heterogeneity and Tumour Evolution in

Recruiting
  • Thyroid Cancer
  • Sample collection only
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Apr 28, 2023

Hepatobiliary Cancer, Pancreatic Cancer, Hepatocellular Carcinoma Trial in Orange (ctDNA Blood Collection)

Not yet recruiting
  • Hepatobiliary Cancer
  • +5 more
  • ctDNA Blood Collection
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Aug 9, 2022

ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer Trial (Elacestrant, Tamoxifen, Letrozole 2.5mg)

Not yet recruiting
  • ER-positive Breast Cancer
  • +3 more
  • (no location specified)
Aug 22, 2022

Resectable Pancreatic Cancer Trial in Denmark (ctDNA)

Recruiting
  • Resectable Pancreatic Cancer
  • ctDNA
  • Aalborg, Denmark
  • +4 more
Mar 27, 2023

Metastatic Colorectal Cancer Trial in Gainesville (Signatera ctDNA assay, pre-specified sequence of FDA-approved drugs and drug

Recruiting
  • Metastatic Colorectal Cancer
  • Signatera ctDNA assay
  • pre-specified sequence of FDA-approved drugs and drug combinations
  • Gainesville, Florida
    University of Florida
Aug 9, 2022

Colorectal Cancer, Liver Metastases, Circulating Tumor Cell Trial in GuangZhou (Colorectal resection surgery., FOLFOX chemo

Recruiting
  • Colorectal Cancer
  • +3 more
  • Colorectal resection surgery.
  • +2 more
  • GuangZhou, Guangdong, China
    The Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 3, 2023

Improve Early Detection of Cancer Recurrence in High-Risk

Recruiting
  • Stage III Melanoma
  • Stage IV Cutaneous Melanoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Oct 6, 2022

    ctDNA Assay in Patients With Resectable Pancreatic Cancer

    Recruiting
    • Pancreas Cancer
      • Oklahoma City, Oklahoma
        University of Oklahoma
      Jun 10, 2022

      MRD Application in Colorectal Cancer Patients

      Recruiting
      • Colorectal Cancer
      • +2 more
        • Jinan, Shandong, China
          Jinan central hospital affiliated to Shandong First Medical Univ
        Sep 1, 2023

        Colorectal Cancer Trial in Guangzhou (Detection of ctDNA methylation)

        Recruiting
        • Colorectal Cancer
        • Detection of ctDNA methylation
        • Guangzhou, Guangdong, China
          Nanfang Hospital, Southern Medical University
        Sep 25, 2022

        ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer

        Not yet recruiting
        • Rectal Cancer
        • Non Metastatic Rectal Cancer
        • ctDNA
        • Boston, Massachusetts
        • +1 more
        Nov 17, 2022

        Cancer Trial in New Orleans, Allentown

        Recruiting
        • Cancer
          • New Orleans, Louisiana
          • +1 more
          Oct 14, 2022

          Lung Cancer Stage III Trial (ctDNA)

          Not yet recruiting
          • Lung Cancer Stage III
          • ctDNA
          • (no location specified)
          Oct 26, 2023

          NSCLC Trial (Almonertinib Envafolimab)

          Not yet recruiting
          • Non-small Cell Lung Cancer
          • Almonertinib Envafolimab
          • (no location specified)
          Sep 10, 2022

          Adenocarcinoma Esophagus Trial in Milwaukee (Circulating tumor DNA(ctDNA) level measurement)

          Recruiting
          • Adenocarcinoma Esophagus
          • Circulating tumor DNA(ctDNA) level measurement
          • Milwaukee, Wisconsin
            Froedtert Hospital and the Medical College of Wisconsin
          May 23, 2022

          Cancer Colorectal Trial (a multi-locus blood-based assay)

          Not yet recruiting
          • Cancer Colorectal
          • a multi-locus blood-based assay
          • (no location specified)
          Sep 7, 2022

          Colon Adenocarcinoma, Colorectal Cancer Trial in Orange (drug, combination product, diagnostic test)

          Recruiting
          • Colon Adenocarcinoma
          • Colorectal Cancer
          • Orange, California
            Chao Family Comprehensive Cancer Center, University of Californi
          May 24, 2022

          Gallbladder Carcinoma Trial in Shanghai (gemcitabine and oxaliplatin., Afatinib)

          Recruiting
          • Gallbladder Carcinoma
          • Shanghai, Shanghai, China
          • +1 more
          Dec 21, 2022